These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26343113)

  • 1. Intraventricular Recombinant Tissue Plasminogen Activator in Treatment of Aneurysmal Intraventricular Hemorrhage: A Meta-Analysis.
    Shi L; Xu L; Shi L; Brandon D; Chen S; Zhang J
    Curr Drug Targets; 2017; 18(12):1399-1407. PubMed ID: 26343113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.
    Findlay JM; Jacka MJ
    Neurosurgery; 2004 Sep; 55(3):532-7; discussion 537-8. PubMed ID: 15335420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.
    Kramer AH; Roberts DJ; Holodinsky J; Todd S; Hill MD; Zygun DA; Faris P; Wong JH
    Neurocrit Care; 2014 Oct; 21(2):275-84. PubMed ID: 24627207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Fibrinolytic Therapy for Intraventricular Hemorrhage: A Meta-Analysis of Randomized Controlled trials.
    Wang D; Liu J; Norton C; Liu M; Selim M
    World Neurosurg; 2017 Nov; 107():1016-1024.e1. PubMed ID: 28778779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracisternal rt-PA during early surgery for aneurysmal subarachnoid hemorrhage: an Italian report.
    Tomasello F; D'Avella D
    J Neurosurg Sci; 1993 Jun; 37(2):71-5. PubMed ID: 8301373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling.
    Hall B; Parker D; Carhuapoma JR
    Neurocrit Care; 2005; 3(2):153-6. PubMed ID: 16174886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol for Aneurysmal Subarachnoid Hemorrhage: An Updated Systematic Review and Meta-Analysis.
    Liu J; He J; Chen X; Feng Y; Wang C; Awil MA; Wang Y; Tian Y; Hou D
    Cerebrovasc Dis; 2022; 51(2):138-148. PubMed ID: 35288494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.
    Hariton GB; Findlay JM; Weir BK; Kasuya H; Grace MG; Mielke BW
    Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage.
    Witsch J; Roh DJ; Avadhani R; Merkler AE; Kamel H; Awad I; Hanley DF; Ziai WC; Murthy SB
    JAMA Netw Open; 2021 Dec; 4(12):e2135773. PubMed ID: 34860246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex Clearance Mechanisms After Intraventricular Hemorrhage and rt-PA Treatment-a Review on Clinical Trials.
    Bosche B; Mergenthaler P; Doeppner TR; Hescheler J; Molcanyi M
    Transl Stroke Res; 2020 Jun; 11(3):337-344. PubMed ID: 31522408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
    Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
    No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Sasaki T; Ohta T; Kikuchi H; Takakura K; Usui M; Ohnishi H; Kondo A; Tanabe H; Nakamura J; Yamada K
    Neurosurgery; 1994 Oct; 35(4):597-604; discussion 604-5. PubMed ID: 7808602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular Tissue Plasminogen Activator and Shunt Dependency in Aneurysmal Subarachnoid Hemorrhage Patients With Cast Ventricles.
    Catapano JS; Rumalla K; Karahalios K; Srinivasan VM; Labib MA; Cole TS; Baranoski JF; Rutledge C; Rahmani R; Jadhav AP; Ducruet AF; Albuquerque FC; Zabramski JM; Lawton MT
    Neurosurgery; 2021 Nov; 89(6):973-977. PubMed ID: 34460915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage.
    Fountas KN; Kapsalaki EZ; Parish DC; Smith B; Smisson HF; Johnston KW; Robinson JS
    South Med J; 2005 Aug; 98(8):767-73. PubMed ID: 16144170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intraventricularly administered low-dose recombinant tissue plasminogen activator on interleukin 1-beta and transforming growth factor beta concentrations in cerebrospinal fluid of patients with primary intracerebral hemorrhage associated with intraventricular hemorrhage: A retrospective study.
    Sošić M; Antončić I; Tarčuković J; Dunatov S; Šustić A; Ćurko-Cofek B; Sotošek V
    Medicine (Baltimore); 2020 May; 99(20):e19966. PubMed ID: 32443298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.
    Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH
    Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage.
    Etminan N; Beseoglu K; Eicker SO; Turowski B; Steiger HJ; Hänggi D
    Stroke; 2013 Aug; 44(8):2162-8. PubMed ID: 23735957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
    Wang X; Li YM; Li WQ; Huang CG; Lu YC; Hou LJ
    PLoS One; 2012; 7(10):e47778. PubMed ID: 23082215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.